MAMC Pharmacy Series: Weight Loss through the VA/DoD
This asynchronous/home study is intended to provide an update to current disease state management for weight loss at the pharmacy department to update and support pharmacists and pharmacy technicians to have the most up-to-date information due to the new class of medications GLP1s that have significantly changed the management of weight loss.
Target Audience
This activity provides continuing education for pharmacists and pharmacy technicians. A certificate of attendance is available for other attendees.
Learning Objectives
- Define clinically meaningful weight loss.
- Recognize the basis for the current VA/DoD clinical practice guideline for the management of adult overweight and obesity 2020.
- Identify TriCare coverage and the agents that are available for weight loss both pharmaceutical and non-pharmaceutical.
- Explain the differences, risks and benefits of the new GLP-1/GIP agents for weight loss.
- Describe role in counseling and patient care.
Mark Nolan, MSPM, BCPS, PharmD. Presenter has no financial or non-financial relationships to disclose.
Disclosure: DHA J-7 staff, planners, authors, faculty, and content reviewers for this educational activity have no relevant financial or non-financial relationships to disclose.
Available Credit
- 1.00 ACPE-Pharm
UAN:
No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity. - 1.00 ACPE-Tech
UAN:
No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity. - 1.00 Attendance
Requirements: CE/CME certificates are awarded to participants who fully complete the activity, successfully submit the evaluation survey, and pass the posttest. The deadline to claim credit is Jan 11, 2026.
Access Code: Some activities require an access code to register or claim credit. Please contact the organization providing the activity for the access code. The Continuing Education Program Office (CEPO) does not provide access codes.
Accommodations: Please contact the course instructor to inquire about accommodations. For additional technical support, email [email protected].